Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TCRαβ-Depleted Haploidentical Grafts Are a Safe Alternative to HLA-Matched Unrelated Donor Stem Cell Transplants for Infants with Severe Combined Immunodeficiency

19 Mar 2022

Abstract excerpt

Hematopoietic stem cell transplantation and gene therapy are the only curative therapies for severe combined immunodeficiency (SCID). In patients lacking a matched donor, TCRαβ/CD19-depleted haploidentical family donor transplant (TCRαβ-HaploSCT) is a promising strategy. Conditioned transplant in SCID correlates to better myeloid chimerism and reduced immunoglobulin dependency. We studied transplant outcome in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hematopoietic Stem Cell Transplantation
Share to Immunodeficiency and Autoimmune Disorders
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35305204
DOI: 10.1007/s10875-022-01239-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TCRαβ-Depleted Haploidentical Grafts Are a Safe Alternative to HLA-Matched Unrelated Donor Stem Cell Transplants for Infants with Severe Combined ImmunodeficiencyPMID 35305204Read ↗

Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.Semantic proximity Read ↗

Unrelated umbilical cord blood transplantation using a noval conditioning regimen for small month-old infants with rare non-malignant disordersSemantic proximity Read ↗

Unrelated umbilical cord blood transplantation using a noval conditioning regimen for small month-old infants with rare non-malignant disordersSemantic proximity Read ↗

SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.Semantic proximity Read ↗

Improved transplant survival and long-term disease outcome in children with MHC class II deficiency.Semantic proximity Read ↗

Long‐term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and BelgiumSemantic proximity Read ↗

Allogeneic Hematopoietic Stem Cell Transplantation in Infant Leukemia: Vague Prospects? (Series Cases and Brief Review)Semantic proximity Read ↗

Stem cell transplantation in sickle cell disease: therapeutic potential and challenges facedSemantic proximity Read ↗

Allogeneic HSCT in Adolescents and Young Adults With Primary ImmunodeficienciesSemantic proximity Read ↗

One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donorsSemantic proximity Read ↗

Hematopoietic stem cell transplantation and immunosuppressive therapy: implications of clonal haematopoiesisSemantic proximity Read ↗

Children’s Oncology Group’s 2023 Blueprint for Research: Cellular Therapy and Stem Cell TransplantationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.